missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD79a/mb-1 (B-Cell Marker) Ab-1 Mouse Monoclonal Antibody, Epredia™
Ensure accurate, reproducible results in immunohistochemistry, western blotting and immunofluorescence experiments.
Marque: Epredia MS-357-P1ABX
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
A disulphide-linked heterodimer, consisting of mb-1 (or CD79a) and B29 (or CD79b) polypeptides, is non-covalently associated with membrane-bound immunoglobulins on B cells to constitute the B cell Ag receptor. CD79a first appears at pre B cell stage and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in the majority of acute leukemias of precursor B cell type, in B cell lines, B cell lymphomas, and in some myelomas. It is not present in myeloid or T cell lines.Host Species: Mouse
Clone: HM47/A9
Isotype: IgG1/κ
Species Reactivity: Human, Monkey, Horse, Cow, Pig, Rabbit, Guinea Pig, Rat, Mouse and Chicken (Plasma cells). Does not react with opossum.
Epitope: GTYQDVGSLNIADVQ
Immunogen: A synthetic peptide consisting of GTYQDVGSLNIADVQ of human CD79a protein
Molecular Weight: 47 kDa
Positive Control: Raji cells, Lymph node or tonsil
Cellular Localization: Membrane
Recommended for:
- Immunohistochemistry (Formalin/paraffin)
- Western Blotting
- Immunofluorescence
Note:
USA: RUO; Int'l: RUO
Spécification
| CD79a/mb-1 (B-Cell Marker) Ab-1 | |
| Monoclonal | |
| 1mg/mL | |
| Mouse | |
| 100 μL | |
| B-Cell | |
| Bovine, Chicken, Equine, Guinea Pig, Human, Mouse, Non-human Primate, Pig, Rabbit, Rat | |
| IgG2a κ |
| Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot | |
| HM47/A9 | |
| Unconjugated | |
| A synthetic peptide consisting of GTYQDVGSLNIADVQ of human CD79a protein | |
| RUO | |
| Primary | |
| Concentrated |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu